MYC and diffuse large B-cell lymphoma: MYC alteration does not belong to the defining feature of the LymphGen algorithm nor has it been described as a driver in DLBCL by Chapuy et al.29, though its functional relevance as oncogene in DLBCL has been shown by Reddy et al.78.